DPYS encodes dihydropyrimidinase (DHP/DHPase; EC 3.5.2.2), the second enzyme of the reductive pyrimidine catabolic pathway. Acting downstream of dihydropyrimidine dehydrogenase (DPYD) and upstream of beta-ureidopropionase (UPB1), it catalyzes the reversible, Zn2+-dependent hydrolytic ring opening of 5,6-dihydrouracil to N-carbamoyl-beta-alanine (3-ureidopropanoate) and of 5,6-dihydrothymine to N-carbamoyl-beta-aminoisobutyrate. It is a binuclear zinc metalloenzyme of the metallo-dependent (cyclic amidohydrolase / amidohydrolase) hydrolase superfamily, hydantoinase/dihydropyrimidinase family, and forms a homotetramer with two Zn2+ ions bridged by a carbamylated lysine per subunit. The enzyme is cytosolic and most highly expressed in liver and kidney. Loss-of-function variants cause dihydropyrimidinase deficiency (dihydropyrimidinuria), an autosomal recessive disorder with a variable neurological phenotype, and impaired dihydropyrimidinase activity increases the risk of fluoropyrimidine (5-fluorouracil) toxicity.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005829
cytosol
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred cytosolic localization. DHP is a soluble cytosolic metabolic enzyme, consistent with the ISS and Reactome (TAS) cytosol annotations.
Reason: Correct and precise cellular-component annotation for a soluble cytosolic pyrimidine-catabolic enzyme; represents the site where DHP acts.
|
|
GO:0006208
pyrimidine nucleobase catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred participation in pyrimidine nucleobase catabolism. DHP catalyzes the second step of reductive pyrimidine degradation, matching this process.
Reason: Core biological-process annotation, directly consistent with the enzyme's role in dihydropyrimidine ring opening within pyrimidine catabolism.
Supporting Evidence:
file:human/DPYS/DPYS-uniprot.txt
Catalyzes the second step of the reductive pyrimidine
|
|
GO:0004157
dihydropyrimidinase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred dihydropyrimidinase activity across orthologs. This is the defining, experimentally supported molecular function of the gene product.
Reason: Core molecular function; agrees with direct experimental (IDA/IMP) evidence in human and the conserved family activity.
Supporting Evidence:
file:human/DPYS/DPYS-uniprot.txt
Can catalyze the ring opening of 5,6-dihydrouracil
|
|
GO:0004157
dihydropyrimidinase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation from the RHEA:16121 / EC 3.5.2.2 mapping. This correctly maps to dihydropyrimidinase activity and matches the curated catalytic activity.
Reason: Accurate EC/RHEA-based inference of the core molecular function.
Supporting Evidence:
file:human/DPYS/DPYS-uniprot.txt
EC=3.5.2.2
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: InterPro-based electronic localization to the cytoplasm. True but less precise than the cytosol annotations from IBA/ISS/TAS evidence.
Reason: Correct but a broader parent of cytosol; the more specific GO:0005829 (cytosol) annotations better capture the localization.
|
|
GO:0016787
hydrolase activity
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: InterPro (Amidohydro_1) electronic annotation to the broad hydrolase parent. Correct but far less informative than the specific dihydropyrimidinase activity.
Reason: High-level parent of GO:0004157; uninformative given the well-established specific activity.
|
|
GO:0016810
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: InterPro-based electronic annotation to an intermediate hydrolase parent. DHP does hydrolyze a C-N bond, but this is a parent of the specific activity.
Reason: Correct branch but a general parent of GO:0004157 dihydropyrimidinase activity; the specific term is preferred.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding IPI from the HuRI all-by-all binary (Y2H) interactome (interaction with APPBP2/Q92624). Uninformative regarding molecular function.
Reason: High-throughput binary-interactome datapoint that does not convey an informative molecular function; kept per curation policy (not removed) but flagged as over-annotation.
Supporting Evidence:
PMID:32296183
a human 'all-by-all' reference interactome map of human binary protein interactions, or 'HuRI'
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding IPI from a neurodegenerative-disease-focused yeast two-hybrid interactome (multiple IntAct partners). Uninformative regarding molecular function.
Reason: High-throughput Y2H interactome datapoint; not an informative molecular function. Retained per curation policy but flagged as over-annotation.
Supporting Evidence:
PMID:32814053
systematic yeast two-hybrid interaction screening of ∼500 ND-related proteins
|
|
GO:0051219
phosphoprotein binding
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: Electronic annotation transferred from a mouse ortholog via Ensembl Compara. There is no functional evidence that DHP binds phosphoproteins; nothing in the enzyme's structure or biochemistry supports a phosphoprotein-binding role.
Reason: Over-propagated electronic inference with no supporting biology for human DPYS; the protein is a cytosolic metabolic hydrolase, not a phosphoprotein-binding adaptor.
|
|
GO:0004157
dihydropyrimidinase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of dihydropyrimidinase activity from an ortholog (UniProtKB:Q55DL0). Consistent with the direct experimental and IBA evidence.
Reason: Redundant with the experimentally supported core molecular function; correctly assigned.
|
|
GO:0042802
identical protein binding
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: Self-association inferred by similarity (from rat ortholog Q63150). Consistent with the homotetrameric quaternary structure of the human enzyme.
Reason: Reflects the oligomeric (homotetramer) assembly rather than the catalytic core function; biologically plausible but ancillary.
Supporting Evidence:
file:human/DPYS/DPYS-uniprot.txt
Homotetramer.
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:19056867 Large-scale proteomics and phosphoproteomics of urinary exos... |
KEEP AS NON CORE |
Summary: Detected by high-throughput mass spectrometry in the human urinary exosome proteome. DHP is highly expressed in kidney epithelium, so its presence in urinary exosomes is a real detection but does not represent the site of its catalytic function.
Reason: Proteomic detection in secreted exosomes; peripheral to the enzyme's cytosolic metabolic role rather than a functional localization.
Supporting Evidence:
PMID:19056867
LC-MS/MS to profile the proteome of human urinary exosomes
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-73589 |
ACCEPT |
Summary: Reactome-asserted cytosolic localization for the conversion of 5,6-dihydrouracil to 3-ureidopropionate. Matches the enzyme's soluble cytosolic nature.
Reason: Correct, specific localization consistent with IBA/ISS cytosol annotations and the known reaction context.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-73618 |
ACCEPT |
Summary: Reactome-asserted cytosolic localization for the conversion of 5,6-dihydrothymine to 3-ureidoisobutyrate. Matches the enzyme's soluble cytosolic nature.
Reason: Correct, specific localization consistent with the other cytosol annotations.
|
|
GO:0004157
dihydropyrimidinase activity
|
IDA
PMID:10410956 Radiochemical assay for determination of dihydropyrimidinase... |
ACCEPT |
Summary: Direct assay of dihydropyrimidinase activity in human liver homogenates using a radiochemical method that separates dihydrouracil from its ring-opened product N-carbamyl-beta-alanine.
Reason: Direct experimental evidence for the enzyme's core catalytic activity in human tissue.
Supporting Evidence:
PMID:10410956
separation of radiolabeled dihydrouracil from N-carbamyl-beta-alanine by HPLC
|
|
GO:0004157
dihydropyrimidinase activity
|
IMP
PMID:18075467 Genetic regulation of dihydropyrimidinase and its possible i... |
ACCEPT |
Summary: Site-directed mutagenesis and expression of DPYS sequence variants showed that inactivating mutations reduce DHP enzyme activity, supporting that DPYS enables this activity.
Reason: Mutation/expression evidence directly linking the gene product to dihydropyrimidinase activity.
Supporting Evidence:
PMID:18075467
inactivating mutations in
|
|
GO:0004157
dihydropyrimidinase activity
|
IDA
PMID:9718352 Dihydropyrimidinase deficiency: structural organization, chr... |
ACCEPT |
Summary: Expression of the human gene and disease-causing variants in a eukaryotic system demonstrated dihydropyrimidinase activity, with all deficiency mutations reducing it.
Reason: Direct experimental support for the core catalytic function of human DPYS.
Supporting Evidence:
PMID:9718352
we showed that all mutations reduced
|
|
GO:0005829
cytosol
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of cytosolic localization (from rat ortholog Q63150). Consistent with all other cytosol/cytoplasm evidence.
Reason: Correct, specific localization consistent with the IBA/TAS cytosol annotations.
|
|
GO:0006208
pyrimidine nucleobase catabolic process
|
IDA
PMID:9718352 Dihydropyrimidinase deficiency: structural organization, chr... |
ACCEPT |
Summary: DHP-deficiency work characterizing the human gene and its variants supports participation in pyrimidine nucleobase catabolism (the deficiency causes dihydropyrimidinuria, an accumulation of pathway intermediates).
Reason: Core biological-process annotation supported by disease biochemistry and the enzyme's position in the reductive pyrimidine degradation pathway.
Supporting Evidence:
PMID:9718352
Dihydropyrimidinase (DHP) deficiency (MIM 222748) is characterized by
|
|
GO:0006210
thymine catabolic process
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of participation in thymine catabolism. DHP acts on 5,6-dihydrothymine (from thymine reduction), so the thymine-degradation branch is a genuine physiological role.
Reason: Consistent with the enzyme's demonstrated ring opening of 5,6-dihydrothymine within pyrimidine (thymine) catabolism.
Supporting Evidence:
file:human/DPYS/DPYS-uniprot.txt
Can catalyze the ring opening of 5,6-dihydrouracil
|
|
GO:0006212
uracil catabolic process
|
IDA
PMID:10410956 Radiochemical assay for determination of dihydropyrimidinase... |
ACCEPT |
Summary: Direct assay of DHP activity on dihydrouracil (the reduced form of uracil) in human liver supports involvement in uracil catabolism.
Reason: Core biological-process annotation; DHP performs the second committed step of uracil degradation.
Supporting Evidence:
PMID:10410956
separation of radiolabeled dihydrouracil from N-carbamyl-beta-alanine by HPLC
|
|
GO:0006212
uracil catabolic process
|
IMP
PMID:18075467 Genetic regulation of dihydropyrimidinase and its possible i... |
ACCEPT |
Summary: Genetic/expression analysis linking inactivating DPYS mutations to altered uracil catabolism (measured by uracil/dihydrouracil breath tests) supports involvement in uracil catabolism.
Reason: Mutation-based evidence tying DPYS function to in-vivo uracil catabolism.
Supporting Evidence:
PMID:18075467
inactivating mutations in
|
|
GO:0008270
zinc ion binding
|
NAS
PMID:9718352 Dihydropyrimidinase deficiency: structural organization, chr... |
ACCEPT |
Summary: DHP is a binuclear zinc metalloenzyme; the human crystal structure (PDB 2VR2) confirms two Zn2+ ions per subunit bridged by a carbamylated lysine, corroborating zinc ion binding as an integral part of the catalytic mechanism.
Reason: Zinc binding is a defining, structurally confirmed feature of DHP catalysis; correct molecular-function annotation.
Supporting Evidence:
file:human/DPYS/DPYS-uniprot.txt
Binds 2 Zn(2+) ions per subunit.
|
DPYS encodes dihydropyrimidinase (DHP/DHPase; EC 3.5.2.2), the second enzyme of the
three-step reductive pyrimidine catabolic (degradation) pathway, acting downstream of
dihydropyrimidine dehydrogenase (DPYD) and upstream of beta-ureidopropionase (UPB1).
It catalyzes the reversible, Zn2+-dependent hydrolytic ring opening of 5,6-dihydrouracil
to N-carbamoyl-beta-alanine (3-ureidopropanoate) and of 5,6-dihydrothymine to
N-carbamoyl-beta-aminoisobutyrate (3-ureidoisobutyrate).
[file:human/DPYS/DPYS-uniprot.txt "Catalyzes the second step of the reductive pyrimidine
degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyze
the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to
N-carbamyl-amino isobutyrate."]
RHEA:16121, EC 3.5.2.2: 5,6-dihydrouracil + H2O = 3-(carbamoylamino)propanoate + H(+).
[file:human/DPYS/DPYS-uniprot.txt "EC=3.5.2.2"]
Dihydropyrimidinase deficiency (DPYSD, MIM 222748): autosomal recessive disorder of
pyrimidine metabolism, dihydropyrimidinuria, variable phenotype (epileptic/convulsive
attacks, dysmorphism, developmental delay, congenital microvillous atrophy); most
patients asymptomatic. Confers risk of 5-fluorouracil (fluoropyrimidine) toxicity.
[file:human/DPYS/DPYS-uniprot.txt "autosomal recessive disorder of pyrimidine metabolism
characterized by"]
- Mutation analysis of the human gene, first DHP-deficiency mutations; all reduced enzyme
activity in eukaryotic expression. PMID:9718352
id: Q14117
gene_symbol: DPYS
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
DPYS encodes dihydropyrimidinase (DHP/DHPase; EC 3.5.2.2), the second enzyme of the
reductive pyrimidine catabolic pathway. Acting downstream of dihydropyrimidine
dehydrogenase (DPYD) and upstream of beta-ureidopropionase (UPB1), it catalyzes the
reversible, Zn2+-dependent hydrolytic ring opening of 5,6-dihydrouracil to
N-carbamoyl-beta-alanine (3-ureidopropanoate) and of 5,6-dihydrothymine to
N-carbamoyl-beta-aminoisobutyrate. It is a binuclear zinc metalloenzyme of the
metallo-dependent (cyclic amidohydrolase / amidohydrolase) hydrolase superfamily,
hydantoinase/dihydropyrimidinase family, and forms a homotetramer with two Zn2+ ions
bridged by a carbamylated lysine per subunit. The enzyme is cytosolic and most highly
expressed in liver and kidney. Loss-of-function variants cause dihydropyrimidinase
deficiency (dihydropyrimidinuria), an autosomal recessive disorder with a variable
neurological phenotype, and impaired dihydropyrimidinase activity increases the risk of
fluoropyrimidine (5-fluorouracil) toxicity.
existing_annotations:
- term:
id: GO:0005829
label: cytosol
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetically inferred cytosolic localization. DHP is a soluble cytosolic
metabolic enzyme, consistent with the ISS and Reactome (TAS) cytosol annotations.
action: ACCEPT
reason: >-
Correct and precise cellular-component annotation for a soluble cytosolic
pyrimidine-catabolic enzyme; represents the site where DHP acts.
- term:
id: GO:0006208
label: pyrimidine nucleobase catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred participation in pyrimidine nucleobase catabolism. DHP
catalyzes the second step of reductive pyrimidine degradation, matching this process.
action: ACCEPT
reason: >-
Core biological-process annotation, directly consistent with the enzyme's role in
dihydropyrimidine ring opening within pyrimidine catabolism.
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: Catalyzes the second step of the reductive pyrimidine
- term:
id: GO:0004157
label: dihydropyrimidinase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetically inferred dihydropyrimidinase activity across orthologs. This is the
defining, experimentally supported molecular function of the gene product.
action: ACCEPT
reason: >-
Core molecular function; agrees with direct experimental (IDA/IMP) evidence in human
and the conserved family activity.
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: Can catalyze the ring opening of 5,6-dihydrouracil
- term:
id: GO:0004157
label: dihydropyrimidinase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic annotation from the RHEA:16121 / EC 3.5.2.2 mapping. This correctly maps
to dihydropyrimidinase activity and matches the curated catalytic activity.
action: ACCEPT
reason: >-
Accurate EC/RHEA-based inference of the core molecular function.
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: EC=3.5.2.2
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: located_in
review:
summary: >-
InterPro-based electronic localization to the cytoplasm. True but less precise than
the cytosol annotations from IBA/ISS/TAS evidence.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Correct but a broader parent of cytosol; the more specific GO:0005829 (cytosol)
annotations better capture the localization.
- term:
id: GO:0016787
label: hydrolase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro (Amidohydro_1) electronic annotation to the broad hydrolase parent. Correct
but far less informative than the specific dihydropyrimidinase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-level parent of GO:0004157; uninformative given the well-established specific
activity.
- term:
id: GO:0016810
label: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-based electronic annotation to an intermediate hydrolase parent. DHP does
hydrolyze a C-N bond, but this is a parent of the specific activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Correct branch but a general parent of GO:0004157 dihydropyrimidinase activity; the
specific term is preferred.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Bare protein-binding IPI from the HuRI all-by-all binary (Y2H) interactome
(interaction with APPBP2/Q92624). Uninformative regarding molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput binary-interactome datapoint that does not convey an informative
molecular function; kept per curation policy (not removed) but flagged as
over-annotation.
supported_by:
- reference_id: PMID:32296183
supporting_text: a human 'all-by-all' reference interactome map of human binary protein interactions, or 'HuRI'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: >-
Bare protein-binding IPI from a neurodegenerative-disease-focused yeast two-hybrid
interactome (multiple IntAct partners). Uninformative regarding molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput Y2H interactome datapoint; not an informative molecular function.
Retained per curation policy but flagged as over-annotation.
supported_by:
- reference_id: PMID:32814053
supporting_text: systematic yeast two-hybrid interaction screening of ∼500 ND-related proteins
- term:
id: GO:0051219
label: phosphoprotein binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: >-
Electronic annotation transferred from a mouse ortholog via Ensembl Compara. There
is no functional evidence that DHP binds phosphoproteins; nothing in the enzyme's
structure or biochemistry supports a phosphoprotein-binding role.
action: REMOVE
reason: >-
Over-propagated electronic inference with no supporting biology for human DPYS; the
protein is a cytosolic metabolic hydrolase, not a phosphoprotein-binding adaptor.
- term:
id: GO:0004157
label: dihydropyrimidinase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
Sequence-similarity transfer of dihydropyrimidinase activity from an ortholog
(UniProtKB:Q55DL0). Consistent with the direct experimental and IBA evidence.
action: ACCEPT
reason: >-
Redundant with the experimentally supported core molecular function; correctly
assigned.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
Self-association inferred by similarity (from rat ortholog Q63150). Consistent with
the homotetrameric quaternary structure of the human enzyme.
action: KEEP_AS_NON_CORE
reason: >-
Reflects the oligomeric (homotetramer) assembly rather than the catalytic core
function; biologically plausible but ancillary.
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: Homotetramer.
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:19056867
qualifier: located_in
review:
summary: >-
Detected by high-throughput mass spectrometry in the human urinary exosome proteome.
DHP is highly expressed in kidney epithelium, so its presence in urinary exosomes is
a real detection but does not represent the site of its catalytic function.
action: KEEP_AS_NON_CORE
reason: >-
Proteomic detection in secreted exosomes; peripheral to the enzyme's cytosolic
metabolic role rather than a functional localization.
supported_by:
- reference_id: PMID:19056867
supporting_text: LC-MS/MS to profile the proteome of human urinary exosomes
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-73589
qualifier: located_in
review:
summary: >-
Reactome-asserted cytosolic localization for the conversion of 5,6-dihydrouracil to
3-ureidopropionate. Matches the enzyme's soluble cytosolic nature.
action: ACCEPT
reason: >-
Correct, specific localization consistent with IBA/ISS cytosol annotations and the
known reaction context.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-73618
qualifier: located_in
review:
summary: >-
Reactome-asserted cytosolic localization for the conversion of 5,6-dihydrothymine to
3-ureidoisobutyrate. Matches the enzyme's soluble cytosolic nature.
action: ACCEPT
reason: >-
Correct, specific localization consistent with the other cytosol annotations.
- term:
id: GO:0004157
label: dihydropyrimidinase activity
evidence_type: IDA
original_reference_id: PMID:10410956
qualifier: enables
review:
summary: >-
Direct assay of dihydropyrimidinase activity in human liver homogenates using a
radiochemical method that separates dihydrouracil from its ring-opened product
N-carbamyl-beta-alanine.
action: ACCEPT
reason: >-
Direct experimental evidence for the enzyme's core catalytic activity in human
tissue.
supported_by:
- reference_id: PMID:10410956
supporting_text: separation of radiolabeled dihydrouracil from N-carbamyl-beta-alanine by HPLC
- term:
id: GO:0004157
label: dihydropyrimidinase activity
evidence_type: IMP
original_reference_id: PMID:18075467
qualifier: enables
review:
summary: >-
Site-directed mutagenesis and expression of DPYS sequence variants showed that
inactivating mutations reduce DHP enzyme activity, supporting that DPYS enables this
activity.
action: ACCEPT
reason: >-
Mutation/expression evidence directly linking the gene product to dihydropyrimidinase
activity.
supported_by:
- reference_id: PMID:18075467
supporting_text: inactivating mutations in
- term:
id: GO:0004157
label: dihydropyrimidinase activity
evidence_type: IDA
original_reference_id: PMID:9718352
qualifier: enables
review:
summary: >-
Expression of the human gene and disease-causing variants in a eukaryotic system
demonstrated dihydropyrimidinase activity, with all deficiency mutations reducing it.
action: ACCEPT
reason: >-
Direct experimental support for the core catalytic function of human DPYS.
supported_by:
- reference_id: PMID:9718352
supporting_text: we showed that all mutations reduced
- term:
id: GO:0005829
label: cytosol
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
Sequence-similarity transfer of cytosolic localization (from rat ortholog Q63150).
Consistent with all other cytosol/cytoplasm evidence.
action: ACCEPT
reason: >-
Correct, specific localization consistent with the IBA/TAS cytosol annotations.
- term:
id: GO:0006208
label: pyrimidine nucleobase catabolic process
evidence_type: IDA
original_reference_id: PMID:9718352
qualifier: involved_in
review:
summary: >-
DHP-deficiency work characterizing the human gene and its variants supports
participation in pyrimidine nucleobase catabolism (the deficiency causes
dihydropyrimidinuria, an accumulation of pathway intermediates).
action: ACCEPT
reason: >-
Core biological-process annotation supported by disease biochemistry and the
enzyme's position in the reductive pyrimidine degradation pathway.
supported_by:
- reference_id: PMID:9718352
supporting_text: Dihydropyrimidinase (DHP) deficiency (MIM 222748) is characterized by
- term:
id: GO:0006210
label: thymine catabolic process
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
Sequence-similarity transfer of participation in thymine catabolism. DHP acts on
5,6-dihydrothymine (from thymine reduction), so the thymine-degradation branch is a
genuine physiological role.
action: ACCEPT
reason: >-
Consistent with the enzyme's demonstrated ring opening of 5,6-dihydrothymine within
pyrimidine (thymine) catabolism.
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: Can catalyze the ring opening of 5,6-dihydrouracil
- term:
id: GO:0006212
label: uracil catabolic process
evidence_type: IDA
original_reference_id: PMID:10410956
qualifier: involved_in
review:
summary: >-
Direct assay of DHP activity on dihydrouracil (the reduced form of uracil) in human
liver supports involvement in uracil catabolism.
action: ACCEPT
reason: >-
Core biological-process annotation; DHP performs the second committed step of uracil
degradation.
supported_by:
- reference_id: PMID:10410956
supporting_text: separation of radiolabeled dihydrouracil from N-carbamyl-beta-alanine by HPLC
- term:
id: GO:0006212
label: uracil catabolic process
evidence_type: IMP
original_reference_id: PMID:18075467
qualifier: involved_in
review:
summary: >-
Genetic/expression analysis linking inactivating DPYS mutations to altered uracil
catabolism (measured by uracil/dihydrouracil breath tests) supports involvement in
uracil catabolism.
action: ACCEPT
reason: >-
Mutation-based evidence tying DPYS function to in-vivo uracil catabolism.
supported_by:
- reference_id: PMID:18075467
supporting_text: inactivating mutations in
- term:
id: GO:0008270
label: zinc ion binding
evidence_type: NAS
original_reference_id: PMID:9718352
qualifier: enables
review:
summary: >-
DHP is a binuclear zinc metalloenzyme; the human crystal structure (PDB 2VR2)
confirms two Zn2+ ions per subunit bridged by a carbamylated lysine, corroborating
zinc ion binding as an integral part of the catalytic mechanism.
action: ACCEPT
reason: >-
Zinc binding is a defining, structurally confirmed feature of DHP catalysis; correct
molecular-function annotation.
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: Binds 2 Zn(2+) ions per subunit.
core_functions:
- description: >-
Zn2+-dependent hydrolytic ring opening of 5,6-dihydrouracil to N-carbamoyl-beta-alanine
(and 5,6-dihydrothymine to N-carbamoyl-beta-aminoisobutyrate), the second step of
reductive pyrimidine catabolism.
molecular_function:
id: GO:0004157
label: dihydropyrimidinase activity
directly_involved_in:
- id: GO:0006212
label: uracil catabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: Catalyzes the second step of the reductive pyrimidine
- reference_id: PMID:10410956
supporting_text: separation of radiolabeled dihydrouracil from N-carbamyl-beta-alanine by HPLC
- description: >-
Dihydropyrimidinase activity within the broader pyrimidine nucleobase catabolic
pathway, using a binuclear zinc center for catalysis.
molecular_function:
id: GO:0004157
label: dihydropyrimidinase activity
directly_involved_in:
- id: GO:0006208
label: pyrimidine nucleobase catabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: file:human/DPYS/DPYS-uniprot.txt
supporting_text: Binds 2 Zn(2+) ions per subunit.
- reference_id: PMID:9718352
supporting_text: we showed that all mutations reduced
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10410956
title: Radiochemical assay for determination of dihydropyrimidinase activity using
reversed-phase high-performance liquid chromatography.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Radiochemical HPLC assay of dihydropyrimidinase activity in human
liver, separating dihydrouracil from N-carbamyl-beta-alanine; directly supports the
core catalytic activity and uracil catabolic role.
- id: PMID:18075467
title: Genetic regulation of dihydropyrimidinase and its possible implication in
altered uracil catabolism.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Site-directed mutagenesis/expression of DPYS variants shows
inactivating mutations reduce DHP activity and impair uracil catabolism; supports MF
and BP annotations.
- id: PMID:19056867
title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
PubMed-verified. Mass-spec detection of DHP among urinary exosome proteins; supports
the extracellular-exosome localization only as a peripheral, non-core observation.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
PubMed-verified HuRI binary interactome. Source of a bare protein-binding IPI; a
high-throughput datapoint that is not functionally informative for DHP.
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
PubMed-verified neurodegenerative-disease Y2H interactome. Source of a bare
protein-binding IPI; high-throughput and not functionally informative for DHP.
- id: PMID:9718352
title: 'Dihydropyrimidinase deficiency: structural organization, chromosomal localization,
and mutation analysis of the human dihydropyrimidinase gene.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Characterizes the human DPYS gene and the first DHP-deficiency
mutations; eukaryotic expression shows all mutations reduce enzyme activity.
Supports MF, BP, zinc-binding (NAS), and disease context.
- id: Reactome:R-HSA-73589
title: conversion of 5,6-dihydrouracil to 3-ureidopropionate
findings: []
- id: Reactome:R-HSA-73618
title: conversion of 5,6-Dihydrothymine to 3-Ureidoisobutyrate
findings: []
- id: file:human/DPYS/DPYS-uniprot.txt
title: UniProtKB Q14117 DPYS (dihydropyrimidinase) record
findings: []